PIANO CONTRACT SERVICES LIMITED

Financial Health Score: C+

Explanation: Piano Contract Services Limited resembles a patient with a robust long-term constitution that has recently developed an acute condition. While the company remains solvent and has a healthy cash position (liquidity), the most recent financial year (2024-2025) reveals a sudden and significant spike in short-term liabilities and a notable drop in net assets. This prevents a higher score; the patient is stable but exhibiting concerning symptoms that require immediate investigation.

Key Vital Signs

1. Net Assets (The Business's Muscle Mass) * 2025: £21,489 * 2024: £27,912 * Interpretation: The company has experienced a 23% reduction in its overall net worth over the past year. Think of this as muscle wasting; while the patient is still strong enough to function, they are losing mass at an alarming rate compared to the steady growth seen in previous years.

2. Current Liabilities (The Cholesterol Build-up) * 2025: £23,186 * 2024: £7,235 * Interpretation: There has been a massive 220% increase in debts falling due within one year. This is the most critical symptom in the data. Like a sudden spike in blood pressure, this dramatic increase in obligations puts significant stress on the business's circulatory system (cash flow).

3. Current Assets & Liquidity (The Blood Supply) * 2025: £45,575 (Current Ratio: 1.96) * 2024: £36,047 (Current Ratio: 4.98) * Interpretation: The company still has healthy cash flow in terms of current assets versus current liabilities. A current ratio of 1.96 means the business has nearly £2 in short-term assets for every £1 of short-term debt. This is a healthy vital sign, meaning the patient is not in immediate danger of cardiac arrest (insolvency). However, the buffer has shrunk considerably from the previous year's very robust 4.98.

4. Operational Pulse (Employees) * 2025: NIL * 2024: NIL * Interpretation: This is a micro-entity with no employees other than the director. It is a low-overhead business, which is favorable for recovery, but also means the business's health is entirely tied to the director's personal capacity to generate revenue.

Diagnosis

Diagnosis: Acute Liability Hypertension with Equity Erosion

The patient presents with a chronic but stable condition that has recently deteriorated. For nearly a decade, the business showed steady, if modest, growth in net assets (from £658 in 2016 to £27,912 in 2024). However, the 2025 figures show a sudden "bleeding" of equity.

The primary cause for this is the dramatic swelling of current liabilities from £7,235 to £23,186—a jump of nearly £16,000. While current assets also grew (by approximately £9,500), they did not grow fast enough to cover the new debt. This resulted in a net loss of value (net assets dropping by £6,423).

This discrepancy suggests one of two scenarios: 1. The Business is absorbing costs it cannot yet pay for: It may have taken on significant new expenses or creditor balances that have not yet been converted into profitable revenue. 2. Director-related transactions: Given the small scale (Micro-entity) and the director's significant control (Mrs. Hanna owns >75%), the spike in liabilities could be due to a shift in how the director's account is structured, or perhaps a new loan injected into the business that is classed as a current liability.

Despite this, the business is not "sick" in a terminal sense. It is solvent, and total assets still comfortably cover total liabilities. The "immune system" (asset base) is functioning, but the "infection" (rising short-term debt) must be monitored.

Recommendations

1. Investigate the Liability Spike (Diagnostic Testing): The immediate priority is to perform a "biopsy" on the £23,186 liability figure. Determine exactly what this debt consists of. Is it trade creditors? HMRC arrears? A director's loan? Treatment depends entirely on the diagnosis of this specific symptom.
2. Debt Reduction Plan (Lowering the Blood Pressure): If the liabilities are external debts (like suppliers or tax), a structured repayment plan must be implemented to bring these levels back down to the healthier 2024 levels. Prolonged high liabilities will restrict future cash flow.
3. Monitor Cash Conversion (Improving Digestion): Ensure that the £45,575 in current assets is comprised of liquid cash rather than "blocked arteries" (slow-paying debtors). If assets are tied up in money owed by clients, focus on improving credit control to ensure cash is available to meet those spiked liabilities.
4. Review Profitability (Nutritional Intake): The drop in net assets suggests the business consumed more resources than it generated. Review the pricing structure and operational efficiency to ensure that the services provided are generating a healthy margin.